We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Persistence with hepatitis C therapy in the Department of Veterans Affairs.
- Authors
Iqbal, S U; Cunningham, F; Lee, A; Miller, D R; Li, N-C; Cheung, R; Kazis, L
- Abstract
Persistence with Hepatitis C therapy has been identified as a key variable for predicting treatment success. The primary purpose of this study was to assess the persistence with therapy for patients undergoing hepatitis C treatment in the VA healthcare system with two forms of combination therapies: peginterferon alfa-2a with Ribavirin (peg-IFN alpha-2a/Rib) and peginterferon alpha-2b with Ribavirin (peg-IFN alpha-2b/Rib).
- Publication
Journal of clinical pharmacy and therapeutics, 2008, Vol 33, Issue 3, p251
- ISSN
1365-2710
- Publication type
Journal Article
- DOI
10.1111/j.1365-2710.2008.00912.x